Literature DB >> 8421950

Management of intracranial hypertension in head injury: matching treatment with cause.

J D Miller1, I R Piper, N M Dearden.   

Abstract

Raised intracranial pressure (ICP) is common after head injury and strongly associated with mortality and morbidity. Empirical and prophylactic therapy with steroids and barbiturates has proved unsuccessful. Ideally, therapy should be targeted at the predominant cause of the increase in ICP. In head injury these may be (1) an increase in cerebral blood volume best treated by hyperventilation and hypnotic drugs. (2) an increase in brain water content best treated by osmotherapy and (3) increased CSF outflow resistance best treated by CSF drainage. This last cause seldom predominates in head injury. To determine whether it is possible to identify the best therapy in individual head injured patients, we are comparing osmotherapy (mannitol) and hypnotic drugs (thiopentone and gamma-hydroxybutyrate) in selected patients with severe head injury where it is possible to maintain standard conditions of ventilation and stable blood pressure and to measure ICP, CPP, brain electrical activity, PR ratio of the ICP wave form and cerebral AvDO2 before and during each of the two forms of therapy. Effective therapy means that ICP has been reduced to 20 mm Hg with preservation or improvement in CPP. 17 patients have been studied so far and 4 groups identified. Osmotherapy was superior to hypnotic in 5 cases, hypnotic superior to mannitol in 3 cases, both were effective in 5 cases and neither effective in 4 cases. Patients in whom hypnotics were superior tended to be younger, with diffuse rather than focal brain injury, had the highest levels of brain electrical activity prior to treatment and a higher PR ratio.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421950     DOI: 10.1007/978-3-7091-9266-5_22

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  6 in total

1.  Raised intracranial pressure.

Authors:  Laurence T Dunn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

Review 2.  Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations.

Authors:  Mauro Oddo; Daniele Poole; Raimund Helbok; Geert Meyfroidt; Nino Stocchetti; Pierre Bouzat; Maurizio Cecconi; Thomas Geeraerts; Ignacio Martin-Loeches; Hervé Quintard; Fabio Silvio Taccone; Romergryko G Geocadin; Claude Hemphill; Carole Ichai; David Menon; Jean-François Payen; Anders Perner; Martin Smith; José Suarez; Walter Videtta; Elisa R Zanier; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2018-03-02       Impact factor: 17.440

Review 3.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Osmolar therapy in pediatric traumatic brain injury.

Authors:  Tellen D Bennett; Kimberly D Statler; E Kent Korgenski; Susan L Bratton
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

Review 5.  Advances in Intracranial Pressure Monitoring and Its Significance in Managing Traumatic Brain Injury.

Authors:  Usmah Kawoos; Richard M McCarron; Charles R Auker; Mikulas Chavko
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

6.  Decompressive craniectomy in traumatic brain injury: usage and clinical outcome in a single centre.

Authors:  Teodor Svedung Wettervik; Samuel Lenell; Lena Nyholm; Tim Howells; Anders Lewén; Per Enblad
Journal:  Acta Neurochir (Wien)       Date:  2017-12-12       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.